(Total Views: 136)
Posted On: 12/05/2020 3:03:45 PM
Post# of 127178
LXRP, Lexaria Biotech making uplisting progress.
Companies with operations in over 100 countries around the world are testing DehydraTECH for possible use in the smokeless tobacco-derived nicotine industry, in the health and wellness industry, and more.
Lexaria is investigating whether its technology might be useful for more effectively delivering drugs in the fight against certain viruses including SARS-CoV-2 that causes COVID-19.
Lexaria operates a federally-licensed in-house research laboratory and is building a robust intellectual property portfolio with 18 patents granted internationally as of Fall, 2020.
https://www.lexariabioscience.com/
Companies with operations in over 100 countries around the world are testing DehydraTECH for possible use in the smokeless tobacco-derived nicotine industry, in the health and wellness industry, and more.
Lexaria is investigating whether its technology might be useful for more effectively delivering drugs in the fight against certain viruses including SARS-CoV-2 that causes COVID-19.
Lexaria operates a federally-licensed in-house research laboratory and is building a robust intellectual property portfolio with 18 patents granted internationally as of Fall, 2020.
https://www.lexariabioscience.com/
(0)
(0)
Robert
